KOD Stock: Price, Earnings History and SEC Filings
Kodiak Sciences Inc. (KOD) last traded at $99.18, down 1.22% on the latest session and up 4.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.05 against an analyst estimate of $-0.97, a miss of 8.2%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KOD earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $-1.05 | $-0.97 | -8.25% |
| Mar 2026 | May 7, 2026 | $-0.94 | $-0.93 | -1.08% |
| Dec 2025 | Mar 31, 2026 | $-1.04 | $-1.02 | -1.96% |
| Sep 2025 | Nov 13, 2025 | $-1.16 | $-1.07 | -8.41% |
KOD beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
How KOD reacts to earnings
Across its last 8 earnings releases, KOD moved 8.3% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-13 | After close | +3.43% |
| 2026-05-07 | After close | -6.11% |
| 2026-03-31 | After close | +12.30% |
| 2025-11-13 | After close | +3.39% |
| 2025-08-13 | After close | +16.47% |
| 2025-05-14 | After close | -15.48% |
| 2025-03-27 | After close | -4.90% |
| 2024-11-14 | After close | +4.34% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
KOD financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | – | -$230M | -$137M | – | $-4.32 |
| 2024 | – | -$176M | -$118M | – | $-3.35 |
| 2023 | – | -$260M | -$196M | – | $-4.97 |
| 2022 | – | -$334M | -$243M | – | $-6.39 |
| 2021 | – | -$267M | -$199M | – | $-5.16 |
| 2020 | – | -$133M | -$87M | – | $-2.91 |
| 2019 | – | -$47M | -$40M | – | – |
| 2018 | – | -$41M | -$29M | – | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for KOD
- 8-K · Sep 28, 2026Other events, Financial statements and exhibits
- 10-Q · Aug 13, 2026
- 8-K · Aug 13, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 4, 2026Shareholder vote
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 22, 2026
- 10-K · Mar 31, 2026
- 8-K · Mar 31, 2026Results of operations, Financial statements and exhibits
- 8-K · Mar 27, 2026Other events, Financial statements and exhibits
Insider filing activity
KOD insiders filed 6 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
KOD news
- Can Zenkuda's Multi-Indication Potential Drive KOD Stock Higher?Oct 19, 2026 · finance.yahoo.com
About Kodiak Sciences Inc.
Kodiak Sciences Inc. (KOD) is a US-listed public company on Nasdaq. The SEC classifies its business as Biological Products (no Diagnostic Substances). It is incorporated in DE. Its fiscal year ends in December.